VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
AstraZeneca PLC vs Nestle S.A.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisNestle S.A.
NESN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Nestle S.A.'s moat claims, evidence, and risks.
View NESN analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 57 / 100 for Nestle S.A.).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); Nestle S.A. has 7 segments (26.9% in Powdered and Liquid Beverages).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; Nestle S.A. has 6 across 3.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
Nestle S.A.
Powdered and Liquid Beverages
Packaged coffee (instant, roast and ground, portioned) and other powdered beverages (cocoa/malt, creamers)
Global
Consumers (end-users) via retail and e-commerce; plus out-of-home channels
Branded manufacturer and marketer; system operator for portioned coffee (machines + capsules)
26.9%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
Nestle S.A. strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Nestle S.A. segments
Full profile >Powdered and Liquid Beverages
Oligopoly
PetCare
Oligopoly
Nutrition and Health Science
Oligopoly
Prepared dishes and cooking aids
Competitive
Milk products and Ice cream
Competitive
Confectionery
Oligopoly
Water
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.